Serum copper in ovarian carcinoma.
Publication/Presentation Date
3-1-1988
Abstract
The serum copper and CA 125 levels of 31 patients with epithelial ovarian carcinoma were determined. Serum copper was elevated in seven patients and CA 125 was elevated in 22 patients. A rise in serum CA 125 always was associated with disease progression. In comparison, serum copper fluctuation did not correlate with the natural history of the malignancy. We concluded that serum copper determination has no use in epithelial ovarian carcinoma management.
Volume
61
Issue
5
First Page
1015
Last Page
1017
ISSN
0008-543X
Published In/Presented At
Jacobs, A. J., Sommers, G. M., Axelrod, J. H., Galakatos, A. E., Kao, M. S., & Camel, H. M. (1988). Serum copper in ovarian carcinoma. Cancer, 61(5), 1015–1017. https://doi.org/10.1002/1097-0142(19880301)61:5<1015::aid-cncr2820610526>3.0.co;2-t
Disciplines
Medicine and Health Sciences
PubMedID
3422179
Department(s)
Department of Obstetrics and Gynecology
Document Type
Article